Myth that tan skin looks healthier persists for a third of young adults
Nearly a third of Americans (32%) think that a tan makes people look better and healthier, a dangerous beauty standard that ...
Pharmabiz21h
US FDA approves Abbott's breakthrough dissolving stent, Esprit BTK System for people with CLTI below-the-knee
Abbott Park, Illinois Thursday, May 2, 2024, 15:00 Hrs [IST] ...
Daily1d
FDA approves dissolving stent for endovascular treatment of peripheral artery disease below knee
The US Food and Drug Administration has approved Esprit BTK everolimus-eluting scaffold system for chronic limb-threatening ...
InnovationRx: FDA Approves Abbott’s Dissolvable Stents
Autoimmune Disorders: Bristol Myers Squibb has entered into a research agreement with Repertoire to develop vaccines for ...
oncnursingnews2d
Oncology Drugs That Received FDA Approval in April 2024
Throughout April, the FDA approved drugs for the treatment of diseases including solid tumors, lung cancer, multiple myeloma, bladder cancer, and low-grade glioma. Several oncology therapies received ...
FDA approves Labcorp companion diagnostic for Pfizer gene therapy
Labcorp’s diagnostic assay will act as a companion diagnostic for Pfizer’s recently approved haemophilia B gene therapy ...
The American Journal of Managed Care3d
T-Cell Exhaustion in CLL: Allogeneic CAR T Trial Reaching Patients With Unmet Need
"Off the shelf" CAR T-cell therapies could offer a solution in chronic lymphocytic leukemia, where T-cell exhaustion creates ...
The Post-Star3d
FDA brings lab tests under federal oversight in bid to improve accuracy and safety
Makers of medical tests that have long escaped government oversight will have about four years to show that their new ...
devdiscourse3d
Reuters Health News Summary
Philips said it had agreed to pay $1.1 billion to settle all personal injury claims filed in the U.S., ending uncertainty that had slashed its market value over the past three years. US FDA grants ...
GEN3d
Ono to Expand Cancer Portfolio with $2.4B Deciphera Acquisition
Ono Pharmaceutical plans to acquire Deciphera Pharmaceuticals for $2.4 billion, in a deal designed to grow the buyer’s ...
MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer Drug, Pelabresib
MorphoSys faces safety concerns over pelabresib, a myelofibrosis treatment. Physicians report patients transitioning rapidly ...
US FDA approves X4 Pharmaceuticals' therapy for immunodeficiency disease
X4 Pharmaceuticals said on Monday the U.S. FDA has approved its therapy to treat a rare genetic immunodeficiency disease in ...